abstract |
This invention provides methods of preventing, treating, or slowing the progression of fibrosis resulting from a coronavirus infection, particularly an infection by SARS-CoV-2, comprising the administration of a galectin-3 inhibitor, particularly wherein said galectin-3 inhibitor is a pumpkin pectin. |